Related Experiment Videos
High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes
Dagmar Högemann1, Vasilis Ntziachristos, Lee Josephson
1Center for Molecular Imaging Research, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
Bioconjugate Chemistry
|January 17, 2002
Summary
Magnetic resonance imaging (MRI) rapidly screens potential molecular imaging agents. This high-throughput method accelerates the development of targeted contrast agents for earlier disease detection and personalized therapies.
Area of Science:
- Biomedical imaging
- Molecular imaging
- Drug discovery
Background:
- In vivo molecular imaging is crucial for early disease detection and targeted therapy.
- Developing novel reporter probes is hindered by a lack of high-throughput, cell-based screening methods.
Purpose of the Study:
- To develop and validate magnetic resonance imaging (MRI) as a high-throughput screening technique for novel MR reporter agents.
- To assess the utility of MRI for evaluating compound interactions with specific cellular targets.
Main Methods:
- Utilized MRI to screen libraries of peptide-nanoparticle conjugates against target cells.
- Validated MRI findings with radioactive assays to confirm receptor binding and internalization data.
Main Results:
- Demonstrated MRI's capability to rapidly screen thousands of samples simultaneously.
- MRI provided accurate measurements of compound-target interactions.
- Validated receptor binding and internalization data using established radioactive assays.
Conclusions:
- MRI is an effective high-throughput screening method for identifying potential MR reporter agents.
- This technology significantly accelerates the development of target-specific and cell-specific MR contrast agents.
- Accelerated development of contrast agents will advance early disease detection and molecular therapies.